DEPO-PROVERA 500mg/3.3ml Price

Overview

Welcome to Dwaey, specifically on DEPO-PROVERA 500mg/3.3ml page.
This medicine contains an important and useful components, as it consists of
Medroxyprogesterone acetateis available in the market in concentration

Name

Medroxyprogesterone Acetate

Precaution

Before using **Medroxyprogesterone Acetate**, it is essential for patients to consult their healthcare provider, especially regarding the following precautions: - **Cardiovascular Diseases**: Medroxyprogesterone Acetate should be used with caution in patients with a history of **blood clots**, **stroke**, or **heart disease**. There is a risk of developing **thromboembolic events** (e.g., deep vein thrombosis, pulmonary embolism) associated with the drug. - **Breast Cancer**: Progestins like Medroxyprogesterone may increase the risk of **breast cancer**, particularly in women who are already at higher risk. Regular breast examinations and mammograms are recommended during use. - **Liver Disorders**: It should be used cautiously in patients with **liver disease**, as Medroxyprogesterone is metabolized in the liver. Patients with **hepatic impairment** should be monitored for possible **hepatic dysfunction**. - **Depression**: Medroxyprogesterone has been associated with mood changes, including **depression**. Patients with a history of depression or mood disorders should be monitored closely during treatment. - **Pregnancy and Breastfeeding**: Medroxyprogesterone Acetate is contraindicated during pregnancy, especially in the first trimester, as it may harm the fetus. It is also secreted in breast milk, so breastfeeding women should consult their doctor before using this medication. - **Bone Density**: Long-term use of Medroxyprogesterone Acetate can lead to a decrease in bone mineral density, increasing the risk of **osteoporosis** and **fractures**. It is important to monitor bone health regularly.

Indication

Medroxyprogesterone Acetate is a synthetic progestin that is used in several therapeutic contexts: - **Contraception**: Medroxyprogesterone Acetate is widely used as a form of **birth control**. It is available as an **injectable contraceptive** (Depo-Provera), providing protection from pregnancy for up to three months after each injection. - **Endometriosis**: It is used to treat **endometriosis**, a condition where tissue similar to the uterine lining grows outside the uterus, causing pain and infertility. - **Abnormal Uterine Bleeding**: Medroxyprogesterone Acetate is prescribed to treat **abnormal uterine bleeding** due to hormonal imbalances. - **Menopausal Symptoms**: It is sometimes used as part of **hormone replacement therapy (HRT)** to manage symptoms of menopause, particularly to counteract **endometrial hyperplasia** associated with estrogen use. - **Treatment of Cancer**: It may also be used as part of the treatment for certain types of **breast cancer** and **kidney cancer**, as it can inhibit the growth of hormone-sensitive cancer cells.

Contra indication

Medroxyprogesterone Acetate should not be used in the following situations: - **Pregnancy**: It is contraindicated during **pregnancy**, as it can cause birth defects and other pregnancy-related complications. - **Breast Cancer**: The drug is contraindicated in women who have or are suspected to have **breast cancer**, as it can stimulate the growth of certain hormone-sensitive tumors. - **Active or Recent History of Blood Clots**: It is contraindicated in patients with a history of **deep vein thrombosis**, **pulmonary embolism**, or **stroke**. - **Severe Liver Disease**: Patients with severe liver dysfunction or active liver disease (such as **hepatitis** or **cirrhosis**) should avoid this medication. - **Unexplained Vaginal Bleeding**: Medroxyprogesterone should not be used in patients with unexplained vaginal bleeding, as it can mask potential issues like uterine cancer. - **Allergy**: It is contraindicated in patients who have a known allergy or hypersensitivity to **Medroxyprogesterone Acetate** or any of its components.

Side Effect

Common side effects of Medroxyprogesterone Acetate include: - **Irregular bleeding or spotting**: Changes in menstrual bleeding patterns, including **spotting** or absence of menstruation. - **Weight gain**: Some individuals may experience **weight gain** due to fluid retention or appetite changes. - **Headache** and **dizziness**: These are common side effects and may occur especially during the initial stages of treatment. - **Mood changes**: Medroxyprogesterone can cause mood swings, **depression**, and anxiety in some individuals. - **Bone density loss**: Prolonged use can lead to **osteoporosis**, particularly with long-term use as a contraceptive. Bone health should be monitored over time. Serious side effects include: - **Severe allergic reactions**, such as swelling of the face, lips, tongue, or throat (which may cause difficulty breathing or swallowing). - **Blood clots**, which can lead to **deep vein thrombosis**, **pulmonary embolism**, or **stroke**. - **Liver toxicity**, including jaundice or elevated liver enzymes. - **Vision problems**, including blurred vision or vision loss (which should be immediately reported). Patients should contact their healthcare provider if they experience any severe side effects or if they have concerns about the medication’s impact on their health.

Pregnancy Category ID

5

Mode of Action

Medroxyprogesterone Acetate is a synthetic progestin that mimics the effects of the natural hormone **progesterone** in the body. It works by binding to **progesterone receptors**, resulting in several therapeutic effects: - **Endometrial Changes**: It helps regulate the endometrial lining of the uterus, making it thinner and less prone to abnormal growth, which is beneficial in conditions like **endometriosis** and **abnormal uterine bleeding**. - **Contraceptive Effect**: Medroxyprogesterone suppresses **ovulation** (the release of an egg from the ovaries) and thickens **cervical mucus**, making it more difficult for sperm to enter the uterus. - **Hormone Replacement**: When used in combination with estrogen in hormone replacement therapy, Medroxyprogesterone helps counteract the risk of **endometrial hyperplasia** (overgrowth of the uterine lining), a potential side effect of estrogen therapy. - **Anti-Cancer Effects**: In certain cancers, particularly **breast cancer**, Medroxyprogesterone can block the effects of estrogen, slowing tumor growth.

Interaction

Medroxyprogesterone Acetate may interact with several other drugs and substances, potentially affecting its effectiveness or causing harmful effects: - **Enzyme Inducers**: Medications such as **phenytoin**, **carbamazepine**, and **rifampin** can reduce the effectiveness of Medroxyprogesterone Acetate by increasing its metabolism. - **Anticoagulants**: Medroxyprogesterone may alter the effects of **warfarin**, an anticoagulant. Blood clotting tests should be closely monitored in patients using both drugs. - **Corticosteroids**: The use of Medroxyprogesterone with corticosteroids (such as **prednisone**) may enhance the risk of **fluid retention** and **hypertension**. - **Antidiabetic Drugs**: Medroxyprogesterone can influence **blood glucose levels**, potentially reducing the effectiveness of **oral hypoglycemic agents**. Diabetic patients should monitor their blood glucose levels regularly. - **Herbal Supplements**: Certain herbal supplements, such as **St. John’s Wort**, which can induce liver enzymes, may decrease the effectiveness of Medroxyprogesterone. Patients should inform their healthcare provider about all other medications, including over-the-counter drugs and supplements, to avoid harmful interactions.

Pregnancy Category Note

Information not available

Adult Dose

The typical adult dose of Medroxyprogesterone Acetate varies depending on the indication: - **Contraception**: A **150 mg intramuscular injection** every 3 months (or 104 mg subcutaneous injection every 3 months). - **Endometriosis**: **10 mg to 20 mg orally** once daily for 12 to 14 days per month. - **Abnormal Uterine Bleeding**: An initial dose of **5 mg to 10 mg orally** daily for 5 to 10 days may be prescribed. - **Hormone Replacement Therapy**: **2.5 mg to 10 mg orally** daily, usually in combination with estrogen.

Child Dose

The use of Medroxyprogesterone Acetate in children should be carefully monitored by a healthcare provider. The typical pediatric indications include **endometriosis** and **pubertal suppression** in transgender youth. The dose and frequency will depend on the individual’s health status and condition. It is important to consult a pediatric specialist for appropriate dosing in children. As always, patients should consult their healthcare provider before initiating or adjusting any treatment regimen involving Medroxyprogesterone Acetate to ensure safety and efficacy.

Renal Dose

There is no specific renal dose adjustment required for **Medroxyprogesterone Acetate** in patients with **renal impairment**. However, caution should be exercised, and the healthcare provider may need to monitor for any signs of side effects.

Administration

Information not available